Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
Abstract The COVID-19 pandemic has prompted hundreds of laboratories around the world to employ traditional as well as novel technologies to develop vaccines against SARS-CoV-2. The hallmarks of a successful vaccine are safety and efficacy. Analytical evaluation methods, that can ensure the high qua...
Enregistré dans:
Auteurs principaux: | Gautam Sanyal, Anna Särnefält, Arun Kumar |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5f6edf1c7a8e454ca1b8e855c1504b98 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
par: Arun B. Arunachalam, et autres
Publié: (2021) -
Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
par: Sarah Kreps, et autres
Publié: (2021) -
Therapeutic vaccines for allergic disease
par: Danuta Gutowska-Owsiak, et autres
Publié: (2017) -
Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases
par: Velayudhan Mohan Kumar, et autres
Publié: (2021) -
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
par: Andrew Chak-Yiu Lee, et autres
Publié: (2021)